Option Care Health (NASDAQ:OPCH) Receives New Coverage from Analysts at JMP Securities

Research analysts at JMP Securities assumed coverage on shares of Option Care Health (NASDAQ:OPCH) in a research note issued to investors on Tuesday, Marketbeat.com reports. The brokerage set an “outperform” rating and a $36.00 price target on the stock. JMP Securities’ price target points to a potential upside of 16.62% from the stock’s previous close.

Separately, Barrington Research restated an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a research report on Wednesday, April 24th.

Option Care Health Price Performance

NASDAQ:OPCH opened at $30.87 on Tuesday. The business’s 50-day simple moving average is $28.80 and its two-hundred day simple moving average is $30.84. Option Care Health has a 52 week low of $26.11 and a 52 week high of $35.74. The stock has a market cap of $5.37 billion, a PE ratio of 20.31, a P/E/G ratio of 1.46 and a beta of 1.24. The company has a quick ratio of 1.39, a current ratio of 1.77 and a debt-to-equity ratio of 0.74.

Option Care Health (NASDAQ:OPCH) last issued its earnings results on Tuesday, April 23rd. The company reported $0.26 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.04. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. The company had revenue of $1.15 billion for the quarter, compared to the consensus estimate of $1.10 billion. During the same quarter last year, the company earned $0.21 EPS. The firm’s quarterly revenue was up 12.8% on a year-over-year basis. As a group, analysts forecast that Option Care Health will post 1.19 EPS for the current fiscal year.

Institutional Trading of Option Care Health

Several hedge funds have recently modified their holdings of OPCH. Principal Securities Inc. bought a new stake in Option Care Health in the fourth quarter worth $27,000. Parallel Advisors LLC grew its stake in shares of Option Care Health by 130.2% in the 4th quarter. Parallel Advisors LLC now owns 845 shares of the company’s stock worth $28,000 after buying an additional 478 shares in the last quarter. TFO Wealth Partners LLC increased its holdings in shares of Option Care Health by 24,625.0% in the 4th quarter. TFO Wealth Partners LLC now owns 989 shares of the company’s stock worth $33,000 after buying an additional 985 shares during the last quarter. Park Place Capital Corp raised its position in shares of Option Care Health by 48.4% during the 1st quarter. Park Place Capital Corp now owns 1,140 shares of the company’s stock valued at $38,000 after buying an additional 372 shares in the last quarter. Finally, SageView Advisory Group LLC purchased a new stake in shares of Option Care Health during the 1st quarter valued at about $85,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.